Jing-dong H. Zhou
1Department Of Hematology, 8 Dianli Rd
Zhenjiang, 212002, China
Zhenjiang, 212002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Second umbilical cord blood transplantation for relapsed adverse-risk acute myeloid leukemia patient with near-homozygous HLA haplotypes.
Journal: Transplant immunology
Published: March 06, 2026
Comprehensive characterization of VSIR reveals dual epigenetic regulation and immune landscape across hematological malignancies.
Journal: Scientific reports
Published: December 19, 2025
Daratumumab-based salvage therapy enables umbilical cord blood transplantation in multiline refractory, elderly T-lymphoblastic lymphoma: a case report.
Journal: Frontiers in immunology
Published: November 10, 2025
Molecular international prognostic index prognostic model in diffuse large B-cell lymphoma.
Journal: Discover oncology
Published: November 01, 2025
Distinctive Molecular Risk Factors Between MDS and MDS/AML Defined by ICC.
Journal: American journal of hematology
Published: October 13, 2025
Identification and validation of HOXB3 hypomethylation as a novel prognostically epigenetic biomarker in acute myeloid leukemia.
Journal: Frontiers in immunology
Published: September 20, 2025
Nephrotic syndrome and Guillain-Barré syndrome following umbilical cord blood transplantation in acute myeloid leukemia: correlated with COVID-19?
Journal: BMC infectious diseases
Published: September 12, 2025
Clinical Significance of CD109 Expression and Methylation Patterns in Acute Myeloid Leukemia.
Journal: Clinical laboratory
Published: August 08, 2025
Clinical characteristics and outcomes of elderly patients with stage Ⅰ diffuse large B-cell lymphoma: a study by the Jiangsu Cooperative Lymphoma Group (JCLG)
Journal: Zhonghua nei ke za zhi
Published: June 08, 2025
Prognostic value of prolymphocyte percentage in chronic lymphocytic leukemia
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: March 26, 2025
ID1 in hematopoiesis and hematologic disorders: novel potentials of a classic differentiation regulator.
Journal: Cellular & molecular biology letters
Published: March 26, 2025
MiR-218 Exhibits Anti-Leukemia Effects by Targeting CTNND2 in Primary Acute Erythroid Leukemia HEL Cells.
Journal: Cell biochemistry and biophysics
Published: March 07, 2025
Last Updated: 09/26/2026